1. Second Primary Cancer after Diagnosis and Treatment of Cervical Cancer
    Myong Cheol Lim et al, 2016, Cancer Res Treat CrossRef
  2. B‑cell translocation gene 1 serves as a novel prognostic indicator of hepatocellular carcinoma.
    Mitsuro Kanda et al, 2015, Int. J. Oncol. CrossRef
  3. CDCA7L promotes hepatocellular carcinoma progression by regulating the cell cycle
    YUAN TIAN et al, 2013 CrossRef
  4. Effects of recombinant human adenovirus-p53 on the regression of hepatic fibrosis
    Yehong Liu et al, 2016 CrossRef
  5. Clinical utility of PDSS2 expression to stratify patients at risk for recurrence of hepatocellular carcinoma.
    Mitsuro Kanda et al, 2014, Int. J. Oncol. CrossRef
  6. Hepatitis B virus inhibits the expression of CD82 through hypermethylation of its promoter in hepatoma cells
    GUOZHENG YU et al, 2014 CrossRef
  7. TGF-β/Smad signaling during hepatic fibro-carcinogenesis (Review)
    KATSUNORI YOSHIDA et al, 2014 CrossRef
  8. Inhibition of S-phase kinase-associated protein 2-mediated p27 degradation suppresses tumorigenesis and the progression of hepatocellular carcinoma
    MING QI et al, 2015 CrossRef
  9. CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma
    Wei Dai et al, 2016 CrossRef
  10. DUSP28 contributes to human hepatocellular carcinoma via regulation of the p38 MAPK signaling
    DONG WANG et al, 2014 CrossRef
  11. Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma
    Tiffany Hennedige, 2016, WJG CrossRef
  12. Serum protein biomarkers relevant to hepatocellular carcinoma and their detection
    Eric Waidely et al, 2016, Analyst CrossRef
  13. Alpha-l-Fucosidase Immunoassay for Early Detection of Hepatocellular Carcinoma
    Eric Waidely et al, 2017, Anal. Chem. CrossRef
  14. PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma
    Ayesha Khalid et al, 2017, Tumour Biol. CrossRef
  15. Galectin-3 and matrix metalloproteinase-9: Perspective in management of hepatocellular carcinoma
    Nada H Eisa et al, 2015, J Oncol Pharm Pract CrossRef
  16. miR-200a suppresses cell growth and migration by targeting MACC1 and predicts prognosis in hepatocellular carcinoma
    JIYE FENG et al, 2015 CrossRef
  17. Oxidored-nitro domain-containing protein 1 expression is associated with the progression of hepatocellular carcinoma
    DENG-QING LI et al, 2016 CrossRef
  18. NRAGE promotes the malignant phenotype of hepatocellular carcinoma
    DAI SHIMIZU et al, 2016 CrossRef
  19. Dynamin 3 suppresses growth and induces apoptosis of hepatocellular carcinoma cells by activating inducible nitric oxide synthase production
    Chao Gu et al, 2017 CrossRef
  20. Anaplastic lymphoma kinase protein expression predicts micrometastases and prognosis for patients with hepatocellular carcinoma
    JIANHUA LIU et al, 2016 CrossRef
  21. Aberrant expression of melanoma-associated antigen-D2 serves as a prognostic indicator of hepatocellular carcinoma outcome following curative hepatectomy
    RYOJI HASHIMOTO et al, 2015 CrossRef
  22. 6-Methoxyethylamino-numonafide inhibits hepatocellular carcinoma xenograft growth as a single agent and in combination with sorafenib
    Yanning Liu et al, 2017, The FASEB Journal CrossRef
  23. Increased ARPP-19 Expression Is Associated with Hepatocellular Carcinoma
    Haiyan Song et al, 2014, IJMS CrossRef
  24. Animal models as a tool in hepatocellular carcinoma research: A Review
    Nuno Paula Santos et al, 2017, Tumour Biol. CrossRef
  25. Antitumor effect of the Newcastle disease viral hemagglutinin–neuraminidase gene is expressed through an oncolytic adenovirus effect in osteosarcoma cells
    Shuang Chen et al, 2018, Anti-Cancer Drugs CrossRef
  26. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation
    Qiong Wu et al, 2018, Cell Death Dis CrossRef
  27. Expression of hepatic Wnt5a and its clinicopathological features in patients with hepatocellular carcinoma
    Li Wang et al, 2018, Hepatobiliary & Pancreatic Diseases International CrossRef
  28. Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection
    Fei Ji et al, 2018, BMC Cancer CrossRef
  29. Exome Sequencing of Fresh-frozen or Formalin-fixed Paraffin-embedded B6C3F1/N Mouse Hepatocellular Carcinomas Arising Either Spontaneously or due to Chronic Chemical Exposure
    Scott S. Auerbach et al, 2018, Toxicol Pathol CrossRef
  30. Pokemon siRNA Delivery Mediated by RGD-Modified HBV Core Protein Suppressed the Growth of Hepatocellular Carcinoma
    Jing Kong et al, 2015, Human Gene Therapy Methods CrossRef
  31. Prognostic and clinicopathological value of Beclin-1 expression in hepatocellular carcinoma: a meta-analysis
    Zhiqiang Qin et al, 2018, World J Surg Onc CrossRef
  32. Heat Shock Protein 90α-Dependent B-Cell-2-Associated Transcription Factor 1 Promotes Hepatocellular Carcinoma Proliferation by Regulating MYC Proto-Oncogene c-MYC mRNA Stability.
    Xueqiong Zhou et al, 2019, Hepatology CrossRef
  33. JMJD6 promotes hepatocellular carcinoma carcinogenesis by targeting CDK4.
    Junhu Wan et al, 2019, Int J Cancer CrossRef
  34. null
    Victoria Chagoya de Sánchez et al, 2018 CrossRef
  35. NRAGE is a potential diagnostic biomarker of hepatocellular carcinoma
    Wenshuang Zou et al, 2018, Medicine CrossRef
  36. Expanding knowledge on Russula alatoreticula, a novel mushroom from tribal cuisine, with chemical and pharmaceutical relevance
    Somanjana Khatua et al, 2019, Cytotechnology CrossRef
  37. Profiling of LINE-1-Related Genes in Hepatocellular Carcinoma
    Tomoyuki Honda et al, 2019, IJMS CrossRef
  38. The different expression of tumor suppressors, RASSF1A, RUNX3, and GSTP1, in patients with alcoholic Steatohepatitis (ASH) vs non-alcoholic Steatohepatitis (NASH)
    Yue Jia et al, 2019, Experimental and Molecular Pathology CrossRef
  39. TIPE1 induces apoptosis by negatively regulating Rac1 activation in hepatocellular carcinoma cells.
    Z Zhang et al, 0 CrossRef
  40. Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma
    Wan-Jiang Xue et al, 2016, Sci Rep CrossRef
  41. Sensitive diagnosis of alpha-fetoprotein by a label free nanoaptasensor designed by modified Au electrode with spindle-shaped gold nanostructure
    Mohammad Heiat et al, 2019, Microchemical Journal CrossRef
  42. The blockage of Ras/ERK pathway augments the sensitivity of SphK1 inhibitor SKI II in human hepatoma HepG2 cells.
    Caixia Zhang et al, 2013, Biochem. Biophys. Res. Commun. CrossRef
  43. Inhibition of Hedgehog signaling in the gastrointestinal tract: Targeting the cancer microenvironment
    Juanita L. Merchant et al, 2014, Cancer Treatment Reviews CrossRef
  44. The role of the dysfunctional akt-related pathway in cancer: establishment and maintenance of a malignant cell phenotype, resistance to therapy, and future strategies for drug development.
    Gaetano Romano, 2013, Scientifica (Cairo) CrossRef
  45. Attenuation of steatohepatitis, fibrosis, and carcinogenesis in mice fed a methionine-choline deficient diet by CCAAT/enhancer-binding protein homologous protein deficiency
    Kan Toriguchi et al, 2014, J Gastroenterol Hepatol CrossRef
  46. Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma
    Tony Gutschner et al, 2014, Hepatology CrossRef
  47. Urinary transforming growth factor α and serum α-fetoprotein as tumor markers of hepatocellular carcinoma
    Jen-Eing Jeng et al, 2014, Tumor Biol. CrossRef
  48. Homeobox B9 is overexpressed in hepatocellular carcinomas and promotes tumor cell proliferation both in vitro and in vivo
    Fangyi Li et al, 2014, Biochemical and Biophysical Research Communications CrossRef
  49. Evaluation and comparison of microvessel density using the markers CD34 and CD105 in regenerative nodules, dysplastic nodules and hepatocellular carcinoma
    Vanderlei Segatelli et al, 2014, Hepatol Int CrossRef
  50. Ras-induced Epigenetic Inactivation of theRRAD(Ras-related Associated with Diabetes) Gene Promotes Glucose Uptake in a Human Ovarian Cancer Model
    Yan Wang et al, 2014, J. Biol. Chem. CrossRef
  51. The Suppressive Role of SOX7 in Hepatocarcinogenesis
    Chong Wang et al, 2014, PLoS ONE CrossRef
  52. BIRC6 promotes hepatocellular carcinogenesis: Interaction of BIRC6 with p53 facilitating p53 degradation
    Wenqing Tang et al, 2015, Int. J. Cancer CrossRef
  53. Activation of RAS/ERK alone is insufficient to inhibit RXRα function and deplete retinoic acid in hepatocytes
    Ai-Guo Wang et al, 2014, Biochemical and Biophysical Research Communications CrossRef
  54. Tissue Microarray Immunohistochemical Profiles of p53 and pRB in Hepatocellular Carcinoma and Hepatoblastoma
    Abdul Hadi Azlin et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
  55. Reversion-Inducing-Cysteine-Rich Protein With Kazal Motifs (RECK) Gene Single Nucleotide Polymorphism With Hepatocellular Carcinoma: A Case-Control Study
    Dina M. Rasheed Bahgat et al, 2016, J. Clin. Lab. Anal. CrossRef
  56. p53 in liver pathologies—taking the good with the bad
    Meital Charni et al, 2014, J Mol Med CrossRef
  57. Diagnosing Borderline Hepatic Nodules in Hepatocarcinogenesis: Imaging Performance
    Byung Ihn Choi et al, 2015, American Journal of Roentgenology CrossRef
  58. Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anti-cancer therapy
    Hye-Lim Ju et al, 2016, Int. J. Cancer CrossRef
  59. Dynamic metabolic change is indicative of inflammation-induced transformation of hepatic cells
    Bo Peng et al, 2015, The International Journal of Biochemistry & Cell Biology CrossRef
  60. Mechanism studies on anti-HepG2 cell proliferation of phenanthroline derivatives as G-quadruplex DNA stabilizers
    Huiqing Li et al, 2015, Bioorganic & Medicinal Chemistry Letters CrossRef
  61. null
    Aundrietta D. Duncan et al, 2015 CrossRef
  62. IGF-I receptor as an emerging potential molecular-targeted for hepatocellular carcinoma in vitro and in vivo
    Min Yao et al, 2016, Tumor Biol. CrossRef
  63. The transcriptomic G1–G6 signature of hepatocellular carcinoma in an Asian population
    John Carson Allen et al, 2016, Medicine CrossRef
  64. Surgical Indications for Hepatocellular Carcinoma with Non-hypervascular Hypointense Nodules Detected by Gd-EOB-DTPA-Enhanced MRI
    Kazuki Takeishi et al, 2020, Ann Surg Oncol CrossRef
  65. Chitosan Nanoparticles for Therapy and Theranostics of Hepatocellular Carcinoma (HCC) and Liver-Targeting
    Maria Cristina Bonferoni et al, 2020, Nanomaterials CrossRef
  66. Molecular mechanism of hepatitis B virus (HBV) on suppression of raf kinase inhibitor protein (RKIP) expression
    Xiao-Ke Cheng et al, 2017, Oncotarget CrossRef
  67. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma
    Fei Wang et al, 2016, Oncotarget CrossRef
  68. Targeted Gene Silencing BRAF Synergized Photothermal Effect Inhibits Hepatoma Cell Growth Using New GAL-GNR-siBRAF Nanosystem
    Yanling Liu et al, 2020, Nanoscale Res Lett CrossRef
  69. A Lipidomic Signature Complements Stemness Features Acquisition in Liver Cancer Cells
    Irma Magaly Rivas Serna et al, 2020, IJMS CrossRef
  70. The Role of Autophagy in Liver Cancer: Crosstalk in Signaling Pathways and Potential Therapeutic Targets
    Jianzhou Cui et al, 2020, Pharmaceuticals CrossRef
  71. The role of DNA damage and repair in liver cancer
    Rhys Gillman et al, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  72. DNA Damage, Liver Injury, and Tumorigenesis: Consequences of DDX3X Loss
    Chieh-Hsiang Chan et al, 2019, Mol Cancer Res CrossRef
  73. SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein–Dependent Apoptotic Pathway
    Long-Kuan Ran et al, 2016, Clin Cancer Res CrossRef
  74. PCNA-associated factor (KIAA0101/PCLAF) overexpression and gene copy number alterations in hepatocellular carcinoma tissues
    Anchalee Tantiwetrueangdet et al, 2021, BMC Cancer CrossRef
  75. Xmrks the Spot: Fish Models for Investigating Epidermal Growth Factor Receptor Signaling in Cancer Research
    Jerry D. Monroe et al, 2021, Cells CrossRef
  76. Decreased expression of the Nkx2.8 gene correlates with tumor progression and a poor prognosis in HCC cancer
    Lei Qu et al, 2014, Cancer Cell Int CrossRef
  77. Hepatic fibrosis and the microenvironment: fertile soil for hepatocellular carcinoma development.
    Michael C Wallace et al, 0 CrossRef
  78. Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development
    Asaf Shilo et al, 2014, RNA CrossRef
  79. Overexpression of Uric Acid Transporter SLC2A9 Inhibits Proliferation of Hepatocellular Carcinoma Cells
    Xiaoying Han et al, 2019, oncol res CrossRef
  80. Au nanoparticles adorned chitosan-modified magnetic nanocomposite: An investigation towards its antioxidant and anti-hepatocarcinoma activity in vitro
    Xiancheng Ou et al, 2022, Inorganic Chemistry Communications CrossRef
  81. Oncogenic Mutation BRAF V600E Changes Phenotypic Behavior of THLE-2 Liver Cells through Alteration of Gene Expression
    Magdalena Śmiech et al, 2022, IJMS CrossRef
  82. Intravenous Immunoglobulin Inhibits Liver Cancer Progression by Promoting p38MAPK-Associated Apoptosis
    Fengjie Xu et al, 2022, Journal of Oncology CrossRef
    Rafael FERNANDES-FERREIRA et al, 2022, Arq. Gastroenterol. CrossRef
  84. Exosomal miRNA in early-stage hepatocellular carcinoma
    Zhi-Qiang Wu et al, 2023, World J Clin Cases CrossRef
  85. SOCS1 Deficiency Promotes Hepatocellular Carcinoma via SOCS3-Dependent CDKN1A Induction and NRF2 Activation
    Md Gulam Musawwir Khan et al, 2023, Cancers CrossRef
  86. Three‐dimensional co‐culture model employing silica nonwoven fabrics to enhance cell‐to‐cell communication of paracrine signaling between hepatocytes and fibroblasts
    Shohei Ishikawa et al, 2023, Biotech & Bioengineering CrossRef